Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Aileron Therapeutics, Inc. (ALRN - Free Report) is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 10.9% downward over the last 30 days.
CyberArk Software Ltd. (CYBR - Free Report) develops, markets, and sales software-based security solutions and services for organizations to safeguard and monitor their privileged accounts. The Zacks Consensus Estimate for its current year earnings has been revised 2.7% downward over the last 30 days.
eMagin Corporation designs, develops, manufactures, and markets organic light emitting diode displays. The Zacks Consensus Estimate for its current year earnings has been revised 30.8% downward over the last 30 days.
J & J Snack Foods Corp. (JJSF - Free Report) manufactures, markets, and distributes nutritional snack foods and beverages. The Zacks Consensus Estimate for its current year earnings has been revised 8.9% downward over the last 30 days.
Mercury General Corporation (MCY - Free Report) engages in writing personal automobile insurance. The Zacks Consensus Estimate for its current year earnings has been revised 4.1% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Aileron Therapeutics, Inc. (ALRN - Free Report) is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 10.9% downward over the last 30 days.
CyberArk Software Ltd. (CYBR - Free Report) develops, markets, and sales software-based security solutions and services for organizations to safeguard and monitor their privileged accounts. The Zacks Consensus Estimate for its current year earnings has been revised 2.7% downward over the last 30 days.
eMagin Corporation designs, develops, manufactures, and markets organic light emitting diode displays. The Zacks Consensus Estimate for its current year earnings has been revised 30.8% downward over the last 30 days.
J & J Snack Foods Corp. (JJSF - Free Report) manufactures, markets, and distributes nutritional snack foods and beverages. The Zacks Consensus Estimate for its current year earnings has been revised 8.9% downward over the last 30 days.
Mercury General Corporation (MCY - Free Report) engages in writing personal automobile insurance. The Zacks Consensus Estimate for its current year earnings has been revised 4.1% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on JJSF - FREE
Get the latest research report on MCY - FREE
Get the latest research report on CYBR - FREE
Get the latest research report on ALRN - FREE